Kranienervepareser, parese af stemmebåndene og sjældne rapporter om kraftige overfølsomhedsreaktioner er blevet rapporteret under postmarketing overvågning af Abraxane.
Cranial nerve palsies, vocal cord paresis, and rare reports of severe hypersensitivity reactions have been reported during post-marketing surveillance of Abraxane.